In this dual-center retrospective cohort of patients with multiple myeloma from Turkey who survived more than 15 years, which features were associated with long-term continuous remission?
Triplet induction with a good complete response before transplant, low ISS stage, and no high-risk features, despite no maintenance therapy
Quadruplet induction with daratumumab or isatuximab followed by lenalidomide maintenance
High-risk cytogenetics treated with tandem transplant and continuous maintenance